Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Clinical trial NCT05795140 · RECRUITING

Trial details

NCT number: NCT05795140
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atypical Hemolytic Uremic Syndrome

Start date: 2024-05-08
Primary completion: 2032-07-16
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.